Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 196, Issue 9, Pages 1304-1312Publisher
UNIV CHICAGO PRESS
DOI: 10.1086/522428
Keywords
-
Categories
Funding
- NIAID NIH HHS [R01 AI054165-04, R37 AI029168, U01 AI068635] Funding Source: Medline
Ask authors/readers for more resources
A central goal of vaccine research is to identify a vaccine-induced immune response that predicts protection from infection or disease. The term correlate of protection has been used to refer to at least 3 distinct concepts, which has resulted in confusion surrounding this topic. We propose precise definitions of these different concepts of immune correlates, using the nomenclature correlate of risk, level 1 surrogate of protection, and level 2 surrogate of protection. We suggest a general framework for assessing these 3 levels of immune correlates in vaccine efficacy trials. To demonstrate the proposed principles, we analyze data from a 1943 influenza vaccine field trial, supporting Weiss strain A - specific antibody titers as a level 1 surrogate of protection. Other real and simulated examples are also discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available